GPNMB and Alzheimer disease: Given that the extracellular domain of GPNMB can be shed as an extracellular soluble fragment (ECF), it is a potential biomarker candidate for neurological disease, including AD, but different groups disagree as to whether GPNMB is a reliable biomarker of disease progression.